FASEB BioAdvances Impact Factor in Chemistry Journals

FASEB BioAdvances in Chemistry Journals

Journal Country: United Kingdom
Journal Q tier: Q2
Publishing Firm: Wiley-Blackwell Publishing Ltd
History: 2019-2022
Journal Homepage: Not Available
Journal ISSN: 25739832

Research Categories

Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Molecular Medicine (Q2); Physiology (Q2); Cancer Research (Q3)

Impact Score: 2.82
h-Index: 15
SJR: 0.731
Ranking: 6727

About FASEB BioAdvances

FASEB BioAdvances is a journal covering the technologies/fields/categories related to Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Molecular Medicine (Q2); Physiology (Q2); Cancer Research (Q3). It is published by Wiley-Blackwell Publishing Ltd. The overall rank of FASEB BioAdvances is 6727.According to SCImago Journal Rank (SJR), this journal is ranked 0.731. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 15. The best quartile for this journal is Q2.The ISSN of FASEB BioAdvances journal is 25739832.An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. FASEB BioAdvances is cited by a total of 590 articles during the last 3 years (Preceding 2022).

Log in to add a review. Log in

No reviews yet. Be the first to review this journal.